Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Geneste
Hérve Geneste, Neuhofen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110257194 | SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME - The present invention relates to novel oxindole derivatives of the general formula (I), | 10-20-2011 |
Hervé Geneste, Ludwigshafen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090215790 | Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof - The invention relates to novel oxindole derivatives of general formula (I), in which the substituents R | 08-27-2009 |
| 20110065720 | CARBAMATE-SUBSTITUTED OXINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF VASOPRESSIN-DEPENDENT DISEASES - The present invention relates to novel carbamate-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders. | 03-17-2011 |
| 20110077241 | HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM - The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R | 03-31-2011 |
| 20110077253 | AMIDOMETHYL-SUBSTITUTED OXINDOLE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF VASOPRESSIN-DEPENDENT ILLNESSES - The present invention relates to novel amidomethyl-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders. | 03-31-2011 |
| 20110245232 | NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I - The present invention relates to small molecule potentiators of metabotropic receptors, in particular of the mGlu2 receptor. The present invention also relates to the use of these compounds for the prevention or treatment of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The present invention thus provides compounds of formula I | 10-06-2011 |
| 20110245247 | NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS - The present invention relates to small molecule potentiators of metabotropic receptors, in particular of the mGlu2 receptor. The present invention also relates to the use of these compounds for the prevention or treatment of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The present invention thus provides compounds of formula I | 10-06-2011 |
Hervè Geneste, Neuhofen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110118232 | PYRIMIDINE COMPOUNDS AND USE THEREOF - The invention relates to novel pyrimidine compounds of general formula (I), in which: A represents a group C═W or CR | 05-19-2011 |
| 20110245266 | PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR - The invention relates to novel pyridin-2-one compounds of general formula (I), in which A represents a 4- to 6-membered hydrocarbon chain that can have 1 or 2 methyl groups as substituents, wherein 1 or 2 carbon atoms can be replaced by oxygen, a carbonyl group or sulfur, and the hydrocarbon chain can have a double bond or a triple bond; R | 10-06-2011 |
Jean-Francois Geneste, Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20090230249 | Method of Launching into Operational Orbit an Artificial Satellite and Associated Propulsion Device - A method is disclosed for placing a satellite in an operational orbit The satellite is equipped with its own satellite propulsion system as well as a detachable separate propulsion device The satellite and separate propulsion device are launched into a transfer orbit by means of a space launcher The separate propulsion device is controlled by a satellite. The satellite is transferred from the transfer orbit to an intermediate orbit by means of the separate propulsion device. The separate propulsion device is separated from the satellite in the intermediate orbit. The satellite then enters and operational orbit from the intermediate orbit by means of its own satellite propulsion system The intermediate orbit is disposed between the transfer and operational orbits, and is in relatively close proximity to the operational orbit but is far enough away from the operational orbit to prevent possible interferences | 09-17-2009 |
| 20120073682 | TOTAL SYSTEM FOR DISTRIBUTING ENERGY SUCH AS LIQUID HYDROGEN - According to the present disclosure, the system includes a plurality of liquid-hydrogen-producing balloon stations that form a total network for distributing liquid hydrogen, and said balloon stations in the network are positioned at the nearest of said target areas of use, substantially above the latter, such that the transfer of the liquid hydrogen between said production balloon stations and said target areas of use is minimal. | 03-29-2012 |
Jean-François Geneste, Toulouse FR
| Patent application number | Description | Published |
|---|---|---|
| 20110315546 | APPARATUS FOR PRODUCING AND DISPENSING HYDROGEN - The present disclosure relates to an altitude-adjustable apparatus comprising: a platform; a device for controllably raising the altitude of the platform; a water supply combined with said platform; a device for converting water into the components thereof through solar power; and means for liquefying and storing the resulting liquefied hydrogen in tanks, the latter being built into flying bodies that are designed to arrive at a target area and dispense the liquefied hydrogen. | 12-29-2011 |
Nicolas Geneste, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20120105077 | EXCITATION CIRCUIT FOR DC SENSORS - A circuit for exciting at least one DC sensor is provided in which the circuit has a digital regulation controller connected to a main system and to a regulation loop. The main system has a DAC connected to the sensor via a non-inverted amplified path and via an inverted amplified path in order to send sensor excitation signals including a DC component in differential mode. The regulation system includes an ADC connected to the amplified paths. The circuit includes a monitoring system that is connected to the controller in parallel with the converter in order to send signals as a function of an AC component of the signals taken from the amplified paths. The digital controller is arranged to inject a sinewave in common mode into the excitation signals and to analyze signals output by the monitoring system and signals output by the ADC. | 05-03-2012 |
Olivier Geneste, Rueil Malmaison FR
| Patent application number | Description | Published |
|---|---|---|
| 20090099072 | Motif of the Beclin Protein Which Interacts with Anti-Apoptotic Members of the Bcl-2 Protein Family, and Uses - The invention relates to a method of identifying modulators of programmed cell death, comprising an interaction between a motif of Beclin protein and an anti-apoptotic member of the family of Bcl-2 proteins and the detection of said interaction be means of fluorescence polarisation. The modulators identified on the basis of said method are administered to cancer patients in order to induce apoptotic- and/or autophagic-type programmed cell death. The invention also relates to a motif of the Beclin protein which can interact with an anti-apoptic member of the family of Bcl-2 proteins and to the use thereof in order to induce programmed cell death in a cancer patient. | 04-16-2009 |
| 20090325883 | Peptides Which Interact with Anti-Apoptotic Members of the BCL-2 Protein Family, and Uses - The invention lies within the field of seeking out and identifying new peptides which interact with anti-apoptotic members of the Bcl-2 protein family, by means of the two-hybrid system. | 12-31-2009 |
| 20110112104 | TRICYCLIC COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. - Compounds of formula (I): | 05-12-2011 |
| 20110237644 | UBIQUITIN SPECIFIC PROTEASES RESPONSIBLE FOR MCL-1 STABILITY AND USES THEREOF - Use of a polypeptide selected from the group consisting of USP13, USP26, USP38, USP42 or USP46 as a screening tool for an agent for treating cancer. | 09-29-2011 |